Expert consensus on <italic>BRCA1/2</italic> gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Breast cancer remains one of the frequently diagnosed malignant tumors among Chinese women, with hereditary cases accounting for 5%-10% of all diagnoses, where <italic>BRCA1/2</italic> gene mutations serve as the primary genetic predisposition factors. Although targeted therapies like poly (ADP-ribo...
Sábháilte in:
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Editorial Office of China Oncology
2025-07-01
|
| Sraith: | Zhongguo aizheng zazhi |
| Ábhair: | |
| Rochtain ar líne: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.07.010 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|